VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SILO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SILOSilo Pharma, Inc.
$5.66$5M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSILOQuarterly Financials

Silo Pharma, Inc. (SILO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Silo Pharma, Inc. (SILO) quarterly income statement — complete revenue, gross profit & net income history

SILO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue18.03K18.03K18.02K18.02K18.03K18.03K18.02K18.02K18.03K18.03K18.02K18.02K18.03K18.03K18.02K18.02K18.03K18.03K18.02K18.03K
Revenue Growth %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%-0.01%4.88%-18.54%10.68%713.45%
Cost of Goods Sold266.26K20.69K20.69K1.46K1.46K399.86K1.46K1.46K1.46K1.46K1.46K1.46K1.46K1.46K1.46K1.46K1.46K1.46K1.46K1.46K
COGS % of Revenue1477.08%114.77%114.77%8.09%8.1%2218.26%8.09%8.09%8.1%8.1%8.09%8.09%8.1%8.1%8.09%8.09%8.1%8.1%8.09%8.1%
Gross Profit-248.23K-2.66K-2.66K16.57K16.57K-381.84K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K16.57K
Gross Margin %-1377.08%-14.77%-14.77%91.91%91.9%-2118.26%91.91%91.91%91.9%91.9%91.91%91.91%91.9%91.9%91.91%91.91%91.9%91.9%91.91%91.9%
Gross Profit Growth %-1598.44%99.3%-116.07%0%0%-2404.94%0%0%0%0%0%0%0%0%0%0%0.02%113.45%225.84%1776.1%
Operating Expenses1.35M783.86K1.15M1.27M1.11M1.5M1.03M1.02M896.08K1.18M789.96K1.13M820.05K1.67M965.72K510.85K619.48K958.98K480.51K453.42K
OpEx % of Revenue7469.37%4348.5%6373.39%7018.68%6161.58%8295.91%5695.54%5655.15%4971.04%6547.71%4382.6%6277.68%4549.27%9283.95%5357.67%2834.12%3436.56%5319.99%2665.79%2515.34%
Selling, General & Admin333.16K477.86K605.19K547.87K516.73K419.7K509.07K626.52K577.84K843.33K615.47K1M617.14K1.04M589.92K405.18K393.55K548.03K439.99K400.57K
SG&A % of Revenue1848.24%2650.93%3357.5%3039.5%2866.55%2328.31%2824.26%3475.82%3205.59%4678.38%3414.53%5552.47%3423.6%5763.01%3272.82%2247.85%2183.21%3040.24%2441.02%2222.17%
Research & Development1.01M306K543.62K717.25K593.96K1.08M517.55K392.82K318.24K336.96K174.5K130.72K202.91K634.68K375.8K105.68K170.28K475.95K70.51K98.85K
R&D % of Revenue5621.13%1697.58%3015.89%3979.18%3295.03%5967.6%2871.28%2179.33%1765.45%1869.33%968.07%725.21%1125.67%3520.94%2084.85%586.27%944.63%2640.34%391.2%548.35%
Other Operating Expenses000000000000000055.65K-65K-30K-46K
Operating Income-1.59M-786.52K-1.15M-1.25M-1.09M-1.88M-1.01M-1M-879.51K-1.16M-773.4K-1.11M-803.49K-1.66M-949.15K-494.29K-602.91K-942.42K-463.94K-436.85K
Operating Margin %-8846.44%-4363.28%-6388.16%-6926.77%-6069.68%-10414.16%-5603.63%-5563.24%-4879.14%-6455.84%-4290.7%-6185.77%-4457.37%-9192.04%-5265.76%-2742.22%-3344.66%-5228.09%-2573.88%-2423.44%
Operating Income Growth %-45.75%58.1%-14%-24.51%-24.4%-61.31%-30.6%10.06%-9.46%29.77%18.52%-125.58%-33.27%-75.82%-104.58%-13.15%33.09%-20.71%27.08%56.17%
EBITDA-1.59M-783.59K-1.15M-1.25M-1.09M-1.87M-1.01M-929.92K-799.8K-1.11M-659.08K-1.01M-904.74K-1.91M-983.25K-658.4K-602.91K-1.06M-493.94K-482.85K
EBITDA Margin %-8830.15%-4346.98%-6371.86%-6913.05%-6052.53%-10397%-5586.48%-5159.06%-4436.91%-6143.56%-3656.49%-5609.36%-5019.09%-10620.72%-5454.9%-3652.72%-3344.66%-5863.09%-2740.32%-2678.63%
EBITDA Growth %-45.89%58.19%-14.06%-34%-36.41%-69.23%-52.78%8.03%11.6%42.16%32.97%-53.57%-50.06%-81.15%-99.06%-36.36%33.65%-33.82%9.93%59.38%
D&A (Non-Cash Add-back)2.94K2.94K2.94K2.47K3.09K3.09K3.09K0056.29K0000000000
EBIT-1.64M-848.83K-1.11M-1.2M-1.03M-1.79M-927.73K-929.92K-799.8K-1.05M-659.08K-1.01M-904.74K-1.91M-983.25K-658.4K-602.91K-1.06M-493.94K-482.85K
Net Interest Income35.34K9.86K43.72K43.27K59.76K82.73K83.86K75.18K86.31K108.11K115.1K107.72K62.73K68.67K9813774151.05K-483-1.04K
Interest Income38.72K42.56K44.6K44.92K61.83K83.01K84.94K77.04K88.18K108.38K116.18K109.58K64.39K70.86K9813774151.21K00
Interest Expense3.37K32.7K8861.65K2.07K2741.08K1.86K1.87K2731.08K1.86K1.66K2.2K0001644831.04K
Other Income/Expense-52.46K-95.01K41.03K44.26K62.68K146.64K81.24K71K77.85K112.15K113.24K102.03K-102.91K-5.87K-34.09K-164.12K0-114.63K6.96M48.04K
Pretax Income-1.65M-881.53K-1.11M-1.2M-1.03M-1.73M-928.81K-931.78K-801.67K-1.05M-660.16K-1.01M-906.4K-1.66M-983.25K-658.4K-602.91K-1.06M6.49M-388.81K
Pretax Margin %-9137.45%-4890.33%-6160.54%-6681.24%-5721.94%-9600.69%-5152.92%-5169.37%-4447.28%-5833.66%-3662.47%-5619.7%-5028.27%-9224.63%-5454.9%-3652.72%-3344.66%-5864%36014.26%-2156.92%
Income Tax000000000000000005.74K19.13K0
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%-0.54%0.29%0%
Net Income-1.65M-881.53K-1.11M-1.2M-1.03M-1.73M-928.81K-931.78K-801.67K-1.12M-660.16K-1.01M-906.4K-1.66M-983.25K-658.4K-604.07K-1.09M6.39M-461.99K
Net Margin %-9137.45%-4890.33%-6160.54%-6681.24%-5721.94%-9600.69%-5152.92%-5169.37%-4447.28%-6219.77%-3662.47%-5619.7%-5028.27%-9224.63%-5454.9%-3652.72%-3351.12%-6039.53%35423.68%-2562.91%
Net Income Growth %-59.69%49.06%-19.55%-29.25%-28.66%-54.36%-40.7%8.01%11.55%32.57%32.86%-53.85%-50.05%-52.74%-115.4%-42.51%35.09%-37.84%1107.44%66.4%
Net Income (Continuing)-1.65M-881.53K-1.11M-1.2M-1.03M-1.73M-928.81K-931.78K-801.67K-1.05M-660.16K-1.01M-906.4K-1.66M-983.25K-658.4K-602.91K-1.06M6.47M-388.81K
Discontinued Operations000000000-69.6K000000-1.16K-25.9K-87.32K-73.18K
Minority Interest00000000000000000000
EPS (Diluted)-1.80-0.99-1.80-2.85-3.45-5.85-3.30-4.65-4.20-5.85-3.15-4.80-4.35-11.70-7.65-6.15-4.65-8.5547.40-3.60
EPS Growth %47.83%83.03%45.45%38.71%17.86%0%-4.76%3.13%3.45%50%58.82%21.95%6.45%-36.84%-116.14%-70.83%43.64%5%931.58%87.76%
EPS (Basic)-1.80-0.99-1.80-2.85-3.45-5.85-3.30-4.65-4.20-5.85-3.15-4.80-4.35-11.70-7.65-6.15-4.65-8.5547.40-3.60
Diluted Shares Outstanding913.95K887.88K622.09K418.65K298.96K298.96K286.79K203.51K191.13K193.75K207.25K210.26K210.59K142.83K133.38K132.53K131.52K127.9K132.93K129.14K
Basic Shares Outstanding913.95K887.88K622.09K418.65K298.96K298.96K286.79K203.51K191.13K193.75K207.25K210.26K210.59K142.83K133.38K132.53K131.52K126.49K131.52K129.14K
Dividend Payout Ratio--------------------